Citadel Advisors
AFIB

Citadel Advisors’s Acutus Medical Inc AFIB Stock Holding History

Citadel Advisors’s Portfolio AFIB Stock Details AFIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-100
Closed -$20 – 15697
2023
Q4 		$20 Buy
+100
New +$39 ﹤0.01% 14157
2023
Q3 		– Sell
-22,500
Closed -$20K – 15379
2023
Q2 		$20K Buy
22,500
+12,700
+130% +$10.8K ﹤0.01% 12727
2023
Q1 		$7.39K Sell
9,800
-6,300
-39% -$8.21K ﹤0.01% 13732
2022
Q4 		$18.5K Sell
16,100
-9,300
-37% -$7.68K ﹤0.01% 13205
2022
Q3 		$22K Buy
25,400
+1,100
+5% +$1.33K ﹤0.01% 12043
2022
Q2 		$27K Sell
24,300
-29,900
-55% -$25.7K ﹤0.01% 12285
2022
Q1 		$75K Sell
54,200
-5,000
-8% -$10.7K ﹤0.01% 12529
2021
Q4 		$202K Buy
59,200
+43,500
+277% +$245K ﹤0.01% 11840
2021
Q3 		$139K Buy
+15,700
New +$207K ﹤0.01% 12471

Other funds holding AFIB

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors's AFIB Position: Q1 2024 in Review

Citadel Advisors sold out of Acutus Medical Inc (AFIB) in Q1 2024, closing a stake of 107,673 shares — an estimated $21.7K sold.

Citadel Advisors first reported a position in AFIB in Q3 2020 and held it in 10 quarters. The position peaked at $2.82M in Q3 2020. 23 funds tracked by Wall St. Rank hold AFIB as of Q1 2024.

  • Citadel Advisors reported no remaining Acutus Medical Inc position as of Q1 2024 after selling out during the quarter.
  • Citadel Advisors sold 107,673 Acutus Medical Inc shares in Q1 2024, an estimated $21.7K.
  • Citadel Advisors first reported a position in Acutus Medical Inc in Q3 2020 and held it in 10 quarters.
  • Citadel Advisors's Acutus Medical Inc position peaked at $2.82M in Q3 2020.
  • 23 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q1 2024.

Based on Citadel Advisors's 13F filing for Q1 2024, filed 15 May 2024.